Group One Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Group One Trading’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Sell	36,200 -26,100	-42%	-$350K	﹤0.01%	3589
2026 Q1	$929K	Sell	62,300 -30,600	-33%	-$681K	﹤0.01%	2797
2025 Q4	$2.32M	Buy	+92,900	New	+$1.65M	﹤0.01%	2151
2025 Q3	–	Sell	-21,400	Closed	-$91.2K	–	8923
2025 Q2	$91.2K	Buy	21,400 +2,500	+13%	+$11.1K	﹤0.01%	5048
2025 Q1	$71.1K	Buy	18,900 +18,800	+18,800%	+$94.6K	﹤0.01%	4881
2024 Q4	$583	Sell	100 -700	-88%	-$6.99K	﹤0.01%	6986
2024 Q3	$9.55K	Sell	800 -7,500	-90%	-$95.9K	﹤0.01%	5626
2024 Q2	$89.8K	Buy	8,300 +7,100	+592%	+$77K	﹤0.01%	4053
2024 Q1	$13.6K	Sell	1,200 -2,100	-64%	-$27.1K	﹤0.01%	5683
2023 Q4	$46.3K	Buy	+3,300	New	+$44.3K	﹤0.01%	5118

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Group One Trading's OLMA Position: Q2 2026 in Review

Group One Trading reduced its Olema Pharmaceuticals (OLMA) stake by 39% in Q2 2026, selling an estimated $193K and leaving 22,746 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 8 quarters since. The position peaked at $554K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Group One Trading held 22,746 shares of Olema Pharmaceuticals worth $285K as of Q2 2026.
Group One Trading sold 14,434 Olema Pharmaceuticals shares in Q2 2026, an estimated $193K.
Olema Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3994 holding.
Group One Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
Group One Trading's Olema Pharmaceuticals position peaked at $554K in Q1 2026.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.